Effect of ß-interferon and methylprednisolone in COVID-19
Phase 3
- Conditions
- Covid- 19.Covid- 19U07.1
- Registration Number
- IRCT20200825048514N1
- Lead Sponsor
- Yazd University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Age 18- 80 years
Covid-19 infection based on high-resolution computed tomography findings
Progressive and severe hypoxia based on blood oxygen saturation level less than 88% with a reservoir bag mask and flow of 15 liters
Exacerbation of lymphopenia during hospitalization
Exclusion Criteria
Cardiovascular patients
Grade 3 and more liver cirrhosis
Autoimmune diseases
Severe depression and psychosis
Organ transplantation
Kidney failure
Pregnancy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method